drugset / Trial / NCT03537326

Study to Detect Oral Administration of Budesonide in Women.

NCT03537326

Phase 1 Completed 4 enrolled Parc de Salut Mar
NaSingle-groupOpen-labelHealth-services research

Summary

This study aims at identifying analysis strategies to detect oral administration of Budesonide in women; in order for them to be used by the accredited laboratories of the Worl Anti-Doping Agency (WADA).

Timeline

Start
2018-05-22
Primary completion
2018-07-01
Completion
2018-09-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 3 mg Oral

Indications

No indication recorded.